GLI1 and acute lymphoblastic leukemia: In T-ALL cells, AMPK signaling was the most consistently downregulated pathway under serum-depleted conditions, and this coincided with increased GLI1 expression and enhanced sensitivity to HH inhibitors, especially GANT 61.